In relation to cancer, hemopexin was reported to be upregulated in pleural effusions of lung-cancer patients and in plasma of pancreatic-cancer patients before resection [45,46], and the fucosylated form of hemopexin was reported as an accurate serum marker for hepatocellular carcinoma [47,48]. Here, HPX is linked to pancreatic neoplasm.